Features of development and clinical picture of pulmonary hypertension in patients with chronic kidney disease


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Aim. to determine the features of development and clinical picture of pulmonary hypertension (pH) in patients with chronic kidney disease (CKD). Material and methods. бо patients aged 18 to 70 years with a diagnosis of CKD III-V stages underwent examination. Depending on the presence of PH and the stage of the disease, the patients were divided into 4 groups: Group I-20 patients with CKD V stage and PH receiving HD; Group 2-20 patients with CKD V stage and without PH who received HD; Group 3-15 patients with CKD ііі-V stages and without PH; Group 4-5 patients with CKD III-V stages and ph. Results. PH developed at the pre-dialysis stage of CKD at a young age (35.4±і6.і8 years). Patients with PH complained of dyspnea (P1-2= 0.052), edema (P1-2=0.058). With physical examination, increase in systolic BP (P1- 2=0.009, P2-4= 0.004, P3-4= 0.02) and diastolic BP (Р2-4=0.02), right heart enlargement (Р1-2=0.016; Р3-4=0.053) and hepatomegaly (Р1-2=0.0098) were revealed. Radiologically, patients with PH had pleural effusions (P1-2=0.053), signs of venous stasis in the lungs (P1-2=0.053), and cardiomegaly (P2-4=0.017; P3-4=0.047). With spirometry, in patients with PH a decrease in the basic parameters of respiratory function of the lungs were documented. On ECG and EchoCG in patients with pH, left ventricle (LV) hypertrophy (P3-4=0.03), an increased left atrium and right ventricle indices (P1-2=0.0014, P1-3=0.007, Pi-3=0.03), reduced ejection fraction (P1-2=0.007, P2-4=0.002), increased LV myocardial mass (P1-3=0.008), and hydropericardium (P1-2=0.004, P3-4=0.005) were detected. Conclusion. Reduction in renal function led to pathological changes in the lungs and heart with the formation of ph. The risk factors for PH in patients with CKD include violations of excretion of body fluids and hyperhydration.

Full Text

Restricted Access

About the authors

K. Sh Dzheyentaev

Email: JEEN81@MAIL.RU

R. R Kaliyev

References

  1. Galiè N., Humbert M., Vachiery J.L., Gibbs S., Lang I., Torbicki A., Si-monneau G., Peacock A., Vonk Noordegraaf A., Beghetti M., Ghofrani A., Gomez Sanchez M.A., Hansmann G., Klepetko W., Lancellotti P., Matucci M., McDonagh T., Pierard L.A., Trindade P.T., Zompatori M., Hoeper M. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal. 2016; 37: 67-119.
  2. Kiykim A.A., Horoz M., Ozcan T., Yildiz I., Sari S., Genctoy G. Pulmonary hypertension in hemodialysis patients without arteriovenous fistula: the effect of dialyzer composition. Ren Fail. 2010; 32(10): 1148-1152.
  3. Bozbas S.S., Akcay S., Altin C., Bozbas H., Karacaglar E., Kanyilmaz S., Sayin B., Muderrisoglu H., Haberal M. Pulmonary hypertension in patients with end-stage renal disease undergoing renal transplantation. Transplant Proc. 2009; 41(7): 2753-2756.
  4. Unal A., Sipahioglu M., Oguz F., Kaya M., Kucuk H., Tokgoz B., Buyukoglan H., Oymak O., Utas C. Pulmonary hypertension in peritoneal dialysis patients: prevalence and risk factors. Perit. Dial. Int. 2009; 29(2): 191-198.
  5. Kumbar L., Fein P.A., Rafiq M.A., Borawski C., Chattopadhyay J., Avram M.M. Pulmonary hypertension in peritoneal dialysis patients. Adv. Perit. Dial. 2007; 23: 127-131.
  6. Abedini M., Sadeghi M., Naini A.E. et al. Pulmonary hypertension amongpatients on dialysis and kidney transplant recipients. Ren Fail. 2013; 35(4): 560-565.
  7. Li Z., Liang X., Liu S Ye Z., Chen Y., Wang W., Li R., Xu L., Feng Z., Shi W. Pulmonary Hypertension: Epidemiology in Different CKD Stages and Its Association with Cardiovascular Morbidity. PLoS ONE. 2014; 9(12): e114392. doi: 10.1371/journal.pone
  8. Yang Q.M., Bao X.R. Pulmonary hypertension in patients with stage 1-3 chronic kidney disease. Genetics and molecular Research. 2014; 13(3): 5695-5703.
  9. Руденко Т.Е., Васильева М.П., Соломахина Н.И., Кутырина И.М. Факторы развития легочной гипертензии на додиализном этапе хронической болезни почек. Терапевтический архив. 2016; 6: 33-39.
  10. Ramasubbu K., Deswal A., Herdejurgen C., Aguilar D., Frost A.E. A prospective echocardiographic evaluation of pulmonary hypertension in chronic hemodialysis patients in the United States: prevalence and clinical significance. Int. J. Gen. Med. 2010; 3: 279-286.
  11. Yigla M., Fruchter O., Aharonson D., Yanay N., Reisner S.A., Lewin M., Nakhoul F. Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Kidney Int. 2009; 75: 969-975.
  12. Rajiv Agarwal. Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients. Nephrol. Dial. Transplant. 2012; 27: 3908-3914.
  13. Issa N., Krowka M.J., Griffin M.D., Hickson L.J., Stegall M.D., Cosio F.G. Pulmonary hypertension is associated with reduced patient survival after kidney transplantation. Transplantation. 2008; 86(10): 1384-1388.
  14. Havlucu Y., Kursat S., Ekmekci C., Celik P., Serter S., Bayturan O., Dinc G. Pulmonary hypertension in patients with chronic renal failure. Respiration. 2007; 74: 503-510.
  15. Abdelwhab S., Elshinnawy S. Pulmonary hypertension in chronic renalfailure patients. Am. J. Nephrol. 2008; 28: 990-997.
  16. Genctoy G., Arikan S., Gedik O. Secondary hyperparathyroidism is associated with pulmonary hypertension in older patients with chronic kidney disease and proteinuria. Int. Urol. Nephrol. 2015; 47(2): 353-358.
  17. Миррахимов М.М. Высокогорная легочная артериальная гипертония // Материалы всесоюзного симпозиума «Легочные артериальные гипертензии». М.,1988. 48 с.
  18. Tarrass F., Benjelloun M., Medkouri G., Hachim K., Benghanem M.G., Ramdani B. Doppler echocardiograph evaluation of pulmonary hypertension in patients undergoing hemodialysis. Hemodial. Int. 2006; 10: 356-359.
  19. Osama F. Khamis, Tarek Abd El-Hamid Elzyat, Abd el-Rahman Ibrahim Mohammed Ali. Prevalence of pulmonary hypertension among chronic kidney disease patients and its relation to location and blood flow of vascular access. International journal of clinical cardiology 2015; 2: 4.
  20. Pabst S., Hammerstingl C., Hundt F., Gerhardt T., Grohé C., Nickenig G., Woitas R., Skowasch D. Pulmonary Hypertension in Patients with Chronic Kidney Disease on Dialysis and without Dialysis: Results of the PEPPER-Study Plos one. 2012; 7(4): e35310. doi: 10.1371/journal.pone.0035310.
  21. Simonneau G., Robbins I.M., Beghetti M., Channick R.N., Delcroix M., Denton C.P., Elliott C.G., Gaine S.P., Gladwin M.T., Jing Z.C., Krowka M.J., Langleben D., Nakanishi N., Souza R. Updated clinical classification of pulmonary hypertension. J. Am. Coll. Cardiol. 2009; 54(1): 43-54. клиническая нефрология № 2 - 2017
  22. Zoccali C., Torino C., Tripepi R., Tripepi G., D’Arrigo G., Postorino M., Gargani L., Sicari R., Picano E., Mallamaci F. Pulmonary Congestion Predicts Cardiac Events and Mortality in ESRD. J. Am. Soc. Nephrol. 2013; 24: 639-646.
  23. Hekmat R., Boskabady M.H., Khaaavi A., Nazary A. The effect of hemodialysis on pulmonary function tests and respiratory symptoms in patients with chronic renal failure. Pak. J. Med. Sci. 2007; 23(6): 862-866.
  24. Kovacevic P., Dragic S., Rajkovaca Z., Kovacevic Т. The correlation between nitric oxide levels and spirometry in dialyzed patients compared to healthy subjects. Enliven Archive; www.enlivenarchive.org 2014; 1: 1-6.
  25. Nakhoul F., Yigla M., Gilman R., Reisner S.A., Abassi Z. The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access. Nephrol Dial Transplant. 2005; 20(8): 1686-1692.
  26. Маслова И.О., Леншин А.В. Ранняя диагностика поражений легких при хронической почечной недостаточности. Материалы областной науч.-практ. конф. терапевтов «Актуальные вопросы диагностики и лечения внутренних болезней». Благовещенск. 2004; 83-88.
  27. Zoccali C., Puntorieri E., Mallamaci F. Lung congestion as a hidden threat in end-stage kidney disease: a call to action. Nephrol. Dial. Transplant. 2013; 28: 2657-2660.
  28. Сошина Л.Ф., Косьминин В.Д., Ломовцева И.А. Морфофункциональные изменения в органах и тканях у больных с ХПН при проведении гемодиализа. Морфогенез и регенерация: Сб. науч. труд. Курск. 1995; 160-162.
  29. Yigla M., Nakhoul F., Sabag A., Tov N., Gorevich B., Abassi Z., Reisner S.A. Pulmonary hypertension in patients with end-stage renal disease. Chest 2003; 123(5): 1577-1582.
  30. Чупрасов В.Б., Комарова Е.Д., Ворон Е.А., Нестерова О.Б. Влияние величины кровотока по артериовенозной фистуле на размеры правых камер сердца у больных с тХПН на программном гемодиализе. Нефрология. 2006; 10: 53-59.
  31. Unal A., Tasdemir K., Oymak S., Duran M., Kocyigit I., Oguz F., Tokgoz B., Sipahioglu M.H., Utas C., Oymak O. The long-term effects of arteriovenous fistula creation on the development of pulmonary hypertension in hemodialysis patients. Hemodial. Int. 2010; 14(4): 398-402.
  32. Acarturk G., Albayrak R., Melek M., Yuksel S., Uslan I., Atli H., Colbay M., Unlu M., Fidan F., Asci Z., Cander S., Karaman O., Acar M. The relationship between arteriovenous fistula blood flow rate and pulmonary artery pressure in hemodialysis patients. Int Urol Nephrol.2008; 40(2): 509-513.
  33. Дудко М.Ю., Шутов Е.В., Капитанов Е.Н., Ермоленко В. М. Влияние нарушений водного баланса на состояние сердечно-сосудистой системы у больных на заместительной почечной терапии. Нефрология и диализ. 2006; 3(8): 244-249.
  34. Floege J., Ketteler M. Vascular calcification in patients with end-stage renal disease. Nephrol. Dial. Transplant. 2004; 19(5): 59-66.
  35. Akmal M., Barndt R.R., Ansari A.N., Mohler J.G., Massry S.G. Excess PTH in CRF induces pulmonary calcification, pulmonary hypertension and right ventricular hypertrophy. Kidney Int. 1995; 47: 158-63.
  36. Yigla M., Keidar Z., Safadi I., Tov N., Reisner S.A., Nakhoul F. Pulmonary calcification in hemodialysis patients: Correlation with pulmonary artery pressure values. Kidney International. 2004; 66: 806-810.
  37. Amin M., Fawzy A., Hamid M.A., Elhendy A. Pulmonary hypertension in patients with chronic renal failure: role of parathyroid hormone and pulmonary artery calcifications. Chest 2003; 124: 2093-2097.
  38. Thadhani R., Appelbaum E., Pritchett Y., Chang Y., Wenger J., Tamez H., Bhan I., Agarwal R., Zoccali C., Wanner C., Lloyd-Jones D., Cannata J., Thompson B.T., Andress D., Zhang W., Packham D., Singh B., Zehnder D., Shah A., Pachika A., Manning W.J., Solomon S.D. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease. The PRIMO randomized controlled trial. JAMA 2012; 307(7): 674-684.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download